Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. (Q33282160)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. |
scientific article |
Statements
1 reference
Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170. (English)
1 reference
Diane V Havlir
1 reference
Robert W Coombs
1 reference
Daniel J Skiest
1 reference
Zhaohui Su
1 reference
Kevin R Robertson
1 reference
Pat Cain
1 reference
Tianna Peterson
1 reference
Amy Krambrink
1 reference
Nasreen Jahed
1 reference
Deborah McMahon
1 reference
AIDS Clinical Trials Group 5170 Study Team
1 reference
6 April 2007
1 reference
1 reference
195
1 reference
10
1 reference
1426-1436
1 reference
Identifiers
1 reference
1 reference